144 related articles for article (PubMed ID: 38214399)
1. Immune and metabolic perturbations in COVID-19-associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells.
Dhaliwal M; Muthu V; Sharma A; Raj K; Rudramurthy SM; Agarwal R; Kaur H; Rawat A; Singh S; Chakrabarti A
Mycoses; 2024 Jan; 67(1):e13679. PubMed ID: 38214399
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
[TBL] [Abstract][Full Text] [Related]
3. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
[TBL] [Abstract][Full Text] [Related]
5. Deficient Phagocytosis in Circulating Monocytes from Patients with COVID-19-Associated Mucormycosis.
Sinha BP; Mehta P; Hoque MA; Bandopadhyay P; Nandi A; Saha I; Nandi Mitra A; Mondal A; Bhattacharjee B; Chamilos G; Pandey R; Basu K; Ganguly D
mBio; 2023 Jun; 14(3):e0059023. PubMed ID: 37052373
[TBL] [Abstract][Full Text] [Related]
6. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
7. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
Muthu V; Agarwal R; Patel A; Kathirvel S; Abraham OC; Aggarwal AN; Bal A; Bhalla AS; Chhajed PN; Chaudhry D; Garg M; Guleria R; Krishnan RG; Kumar A; Maheshwari U; Mehta R; Mohan A; Nath A; Patel D; Rudramurthy SM; Saxena P; Sethuraman N; Singhal T; Soman R; Thangakunam B; Varghese GM; Chakrabarti A
Lancet Infect Dis; 2022 Sep; 22(9):e240-e253. PubMed ID: 35390293
[TBL] [Abstract][Full Text] [Related]
8. The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of
Montaño DE; Hartung S; Wich M; Ali R; Jungnickel B; von Lilienfeld-Toal M; Voigt K
Front Immunol; 2022; 13():882921. PubMed ID: 36311802
[TBL] [Abstract][Full Text] [Related]
9. Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis.
Shete A; Deshpande S; Sawant J; Warthe N; Thakar M; Madkaikar M; Pradhan V; Rao P; Rohatgi S; Mukherjee A; Anand T; Satija A; Sharma Velamuri P; Das M; Deasi N; Kumar Tembhurne A; Yadav R; Pawaskar S; Rajguru C; Sankhe LR; Chavan SS; Panda S
Immunobiology; 2023 May; 228(3):152384. PubMed ID: 37071959
[TBL] [Abstract][Full Text] [Related]
10. Perturbations of immune landscape in COVID-19 associated mucormycosis.
Desai N; Pradhan V; Chougule D; Tiwari S; Mandke C; Yadav RM; Athvale A; Kawle J; Pai V; Pawaskar S; Kharkar H; Bhosale S; Parab A; Ansari S; Kumar KH; Mhashal S; Redkar N; Madkaikar M
Mycoses; 2023 Mar; 66(3):226-236. PubMed ID: 36380699
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.
Dave TV; Nair AG; Joseph J; Freitag SK
Orbit; 2022 Dec; 41(6):670-679. PubMed ID: 35856238
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
Khatri A; Chang KM; Berlinrut I; Wallach F
J Mycol Med; 2021 Jun; 31(2):101125. PubMed ID: 33857916
[TBL] [Abstract][Full Text] [Related]
14. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-Associated Pulmonary Mucormycosis.
Krishna V; Bansal N; Morjaria J; Kaul S
J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887466
[TBL] [Abstract][Full Text] [Related]
16. Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case-control study.
Muthu V; Dhaliwal M; Sharma A; Nair D; Kumar HM; Rudramurthy SM; Sehgal IS; Choudhary H; Panda N; Chakrabarti A; Agarwal R
Mycopathologia; 2022 Aug; 187(4):355-362. PubMed ID: 35727491
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19.
Maher AK; Burnham KL; Jones EM; Tan MMH; Saputil RC; Baillon L; Selck C; Giang N; Argüello R; Pillay C; Thorley E; Short CE; Quinlan R; Barclay WS; Cooper N; Taylor GP; Davenport EE; Dominguez-Villar M
Nat Commun; 2022 Dec; 13(1):7947. PubMed ID: 36572683
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap.
Crone CG; Helweg-Larsen J; Steensen M; Arendrup MC; Helleberg M
J Mycol Med; 2022 Mar; 32(1):101228. PubMed ID: 34826672
[TBL] [Abstract][Full Text] [Related]
20. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
Prokop JW; Hartog NL; Chesla D; Faber W; Love CP; Karam R; Abualkheir N; Feldmann B; Teng L; McBride T; Leimanis ML; English BK; Holsworth A; Frisch A; Bauss J; Kalpage N; Derbedrossian A; Pinti RM; Hale N; Mills J; Eby A; VanSickle EA; Pageau SC; Shankar R; Chen B; Carcillo JA; Sanfilippo D; Olivero R; Bupp CP; Rajasekaran S
Front Immunol; 2021; 12():694243. PubMed ID: 34335605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
